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Research
The association between cardiovascular out­
comes and exposure to ambient levels of air 
pollutants is well supported in the litera­
ture (Dockery et al. 1993; Laden et al. 
2006; Miller et al. 2007; Pope et al. 2002; 
Puett et al. 2008, 2009). Studies have also 
reported that individuals with diabetes mel­
litus (DM) have increased susceptibility for 
adverse cardiovascular outcomes related to 
acute increases in exposures to air pollution 
(Bateson and Schwartz 2004; Dubowsky et al. 
2006; O’Neill et al. 2005; Peel et al. 2007; 
Zanobetti and Schwartz 2001). What is not 
known is whether DM is in itself an adverse 
outcome of air pollution.
There are few studies exploring a potential 
causal role of air pollution in DM develop­
ment. Brook et al. (2008) studied the relation­
ship between DM and exposures to traffic 
pollution among more than 7,600 men and 
women in two Canadian cities using nitrogen 
dioxide (NO2) measurements taken from 2002 
to 2004. Meta­analytic models showed a statis­
tically significant increase in the odds of DM 
among women with each increase in 1­ppb 
exposure to NO2. No association was found 
among male study participants. A case–control 
study reported that prediagnosis average par­
ticulate matter (PM) < 10 µm in aerodynamic 
diameter (PM10) exposure was significantly 
higher for children diagnosed with DM com­
pared with controls (Hathout et al. 2002). 
Finally, diabetes­related mortality has been 
associated with PM and other ambient air pol­
lutant exposures (Kan et al. 2004; Maynard 
et al. 2007; Ostro et al. 2006). However, 
based on studies (Bateson and Schwartz 2004; 
Dubowsky et al. 2006; O’Neill et al. 2005; 
Peel et al. 2007; Zanobetti and Schwartz 2001) 
that showed DM as an effect modifier of air 
pollution–associated DM outcomes, these 
findings may reflect susceptibility rather than 
incidence.
In this study, we used data from two estab­
lished prospective cohorts, the Nurses’ Health 
Study (NHS) and the Health Professionals 
Follow­up Study (HPFS), to examine the 
role of chronic exposures to PM < 2.5 µm in 
aerodynamic diameter (PM2.5), PM10, PM 
between 2.5 and 10 µm in aerodynamic diam­
eter (PM10–2.5), and proximity to roads (as a 
proxy for traffic­related pollutant exposures) 
as risk factors for type 2 DM. Biennial ques­
tionnaires from each of these cohorts and 
detailed monthly exposure modeling provided 
a unique opportunity to control for known 
individual­level risk factors and to estimate 
ambient PM exposures specific to all reported 
mailing addresses for each participant during 
the 13­year follow­up period.
Materials and Methods
Study population. The NHS is a prospective 
cohort study that began in 1976 with 121,700 
female registered nurses age 30–55 years who 
lived in one of 11 states in the United States 
(California, Texas, Florida, Massachusetts, 
Pennsylvania, Ohio, New York, New Jersey, 
Michigan, Connecticut, and Maryland) at 
enrollment. Biennial questionnaires on risk 
factors and health outcomes have been mailed 
to participants from 1976 until the present 
(NHS 2009). The NHS was approved by 
the institutional review board (IRB) of the 
Brigham and Women’s Hospital. 
The HPFS cohort originated in 1986 with 
51,529 male dentists, podiatrists, pharmacists, 
veterinarians, osteopaths, and optometrists 
located throughout the United States who were 
40–75 years of age at enrollment. In 1986, 
the participants returned a mailed question­
naire that collected data on lifestyle character­
istics and medical history. As with the NHS, 
HPFS participants also were mailed question­
naires every 2 years to date (HPFS 2009). The 
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Ba c k g r o u n d: Although studies have found that diabetes mellitus (DM) modifies the impact of 
exposures from air pollution on cardiovascular outcomes, information is limited regarding DM as 
an air pollution-associated outcome.
oBjectives: Using two prospective cohorts, the Nurses’ Health Study (NHS) and the Health 
Professionals Follow-Up Study (HPFS), we investigated the relationship of incident type 2 DM with 
exposures to particulate matter (PM) < 2.5 µm (PM2.5), PM < 10 µm (PM10), and PM between 
2.5 and 10 µm in aerodynamic diameter (PM10–2.5) in the previous 12 months and the distance to 
  roadways.
Me t h o d s : Cases were reported and confirmed through biennial and supplemental questionnaires 
of diagnosis and treatment information. During follow-up from 1989 to 2002, questionnaires pro-
vided information on time-varying covariates and updated addresses. Addresses were geocoded and 
used to assign air pollution exposures from spatiotemporal statistical models.
re s u l t s: Among participants living in metropolitan areas of the northeastern and midwestern 
United States, there were 3,784 incident cases of DM in the NHS, and 688 cases in the HPFS. 
Pooled results from random effects meta-analysis of cohort-specific models adjusted for body mass 
index and other known risk factors produced hazard ratios (HRs) for incident DM with inter-
quartile range (IQR) increases in average PM during the 12 months before diagnosis of 1.03 [95% 
confidence interval (CI), 0.96–1.10] for PM2.5, 1.04 (95% CI, 0.99–1.09) for PM10, and 1.04 
(95% CI, 0.99–1.09) for PM10–2.5. Among women, the fully adjusted HR for living < 50 m versus 
≥ 200 m from a roadway was 1.14 (95% CI, 1.03–1.27).
co n c l u s i o n s: Overall, results did not provide strong evidence of an association between exposure 
to PM in the previous 12 months and incident DM; however, an association with distance to road 
(a proxy marker of exposure to traffic-related pollution) was shown among women.
key w o r d s : air pollution, diabetes, incidence, particulate matter. Environ Health Perspect 
119:384–389 (2011).  doi:10.1289/ehp.1002344 [Online 30 November 2010]PM exposures and diabetes
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HPFS was approved by the Harvard School of 
Public Health IRB. For both of these cohorts, 
baseline IRB approval included returning the 
completed questionnaires, which constituted 
implied consent to use the data in ongoing 
health research. Loss to follow­up in both of 
these cohorts is < 10%.
This study was restricted to NHS and 
HPFS participants living in metropolitan sta­
tistical areas (MSAs) in 13 U.S. contiguous 
northeastern and midwestern states (Maine, 
Vermont, New Hampshire, Massachusetts, 
Rhode Island, Connecticut, New York, 
New Jersey, Delaware, Pennsylvania, Ohio, 
Michigan, and Maryland) from 1989 through 
2002 to facilitate comparisons with previous 
studies (Eftim et al. 2008; Pope et al. 1995, 
2002) and because air pollution monitors 
used to estimate exposures that are sparsely 
distributed outside the MSAs. In addition, 
we excluded persons with a history of dia­
betes at baseline. The final study population 
comprised 74,412 women and 15,048 men, 
with the vast majority of exclusions from 
the original cohort population attributable 
to addresses outside the Northeast and the 
Midwest at baseline, rather than addresses 
outside an MSA. Nurses and health pro­
fessionals were excluded for any period of   
follow­up during which they lived outside 
this region, rather than being censored at the 
time they moved outside the region.
Outcome assessment. Study participants 
who reported a diagnosis of DM on a biennial 
questionnaire were sent an additional ques­
tionnaire to ascertain the month and year of 
diagnosis and information about diagnostic 
tests and treatment. To be considered a con­
firmed case of DM, at least one of the follow­
ing National Diabetes Data Group criteria 
(National Diabetes Data Group 1979) had 
to be met: elevated plasma glucose concen­
trations on at least two different occasions 
(as defined below), one or more DM symp­
toms (e.g., weight loss, thirst, polyuria) and 
a single elevated plasma glucose concentra­
tion, or treatment with hypoglycemic medica­
tion. An elevated plasma glucose concentration 
was defined as a fasting plasma glucose > 140 
mg/dL for cases diagnosed before or during 
1997 or > 126 mg/dL for cases diagnosed after 
1997 (Expert Committee on the Diagnosis 
and Classification of Diabetes Mellitus 1997), 
a random plasma glucose concentration > 200 
mg/dL, or a plasma glucose concentration 
> 200 mg/dL after > 2 hr of oral glucose toler­
ance testing. Comparisons between medical 
records and self­reported DM for subsamples 
of men from the HPFS cohort and women 
from the NHS resulted in confirmation of 
97% and 98% of cases, respectively (Hu et al. 
2001a; Manson et al. 1991).
Exposure assessment. To  ascertain the 
exposure of each participant to air pollution 
at each geocoded address where question­
naires were mailed, we developed separate 
spatiotemporal models to estimate monthly 
PM2.5 and PM10–2.5 exposures. Mailing 
addresses were residential for the women; 
however, some work addresses were included 
as mailing addresses for the men. These mod­
els and their previous use in assessing chronic 
PM exposures among the NHS cohort are 
described in detail elsewhere (Paciorek et al. 
2009; Puett et al. 2008, 2009; Yanosky et al. 
2008, 2009). Briefly, a PM10 model was 
developed first, using monitor data from 
the U.S. Environmental Protection Agency 
(EPA) Air Quality System (AQS; U.S. EPA 
2009), the Visibility Information Exchange 
Web System (VIEWS 2004), the Interagency 
Monitoring of Protected Visual Environments 
(IMPROVE) network, Stacked Filter Unit 
(a predecessor to IMPROVE), Clean Air 
Status and Trends (CASTNet) networks, and 
Harvard research studies such as the Twenty­
four Cities Study and Five Cities Study 
(Spengler et al. 1996; Suh et al. 1997). The 
model also included geographic information 
system (GIS)–derived covariates such as mete­
orology, land use and elevation, population 
density, road network, and point source emis­
sion data. Land use data were from the U.S. 
Geological Survey 1992 National Land Cover 
Data Set (Yanosky et al. 2008). The process 
of estimating PM2.5 exposures was similar to 
the process used to estimate PM10 exposures 
but involved developing separate models for 
PM2.5, before and after 1999, because U.S. 
EPA AQS monitoring data for PM2.5 were 
unavailable before 1999. The pre­1999 PM2.5 
model used a simpler spatiotemporal structure 
to estimate the PM2.5 to PM10 ratio seasonally 
and included estimated extinction coefficients 
from airport visibility data. Finally, PM10–2.5 
exposures were estimated, for each month and 
location, by subtracting each of the modeled 
PM2.5 estimates from each of the modeled 
PM10 estimates. Monitor data were included 
from 922 PM10 sites and 498 PM2.5 sites 
(Paciorek et al. 2009). The PM10 model and 
post­1999 and pre­1999 PM2.5 models were 
evaluated using a cross­validation approach, 
where a subselection of monitors were 
held out to compare predicted values with 
observed values (Paciorek et al. 2009; Yanosky 
et al. 2008, 2009). The models were shown 
to exhibit little bias and high precision. For 
the PM10 model, cross­validation (R2 = 0.62) 
showed the model performed substantially 
better than other approaches (e.g., inverse 
distance weighting cross­validation R2 = 0.29) 
(Yanosky et al. 2008). Cross­validation for the 
PM2.5 model was R2 = 0.77 and 0.69 for post­
1999 and pre­1999 PM2.5 models, respec­
tively (Yanosky et al. 2009). The predicted 
PM10–2.5 levels showed little bias but were less 
precise compared with PM2.5 (Yanosky et al. 
2009). Yanosky et al. (2009) noted that the 
PM2.5 levels in the study area were more spa­
tially homogenous than were the PM10 and 
PM10–2.5 levels.
Distance from each biennially updated 
address to the nearest road was used as a 
proxy for traffic­related air pollution expo­
sure. Specifically, the distance (in meters) 
from each address to the closest U.S. cen­
sus feature class code A1 (roads with limited 
access, typically interstates), A2 (major, non­
interstate roads), or A3 (secondary roads, typi­
cally with more than two lanes) road segment 
was determined using a GIS (ArcGIS, ver­
sion 9.2; ESRI, Redlands, CA) and 2000 U.S. 
Census Topologically Integrated Geographic 
Encoding and Referencing system (TIGER) 
files (U.S. Census 2000). Based on informa­
tion from previous studies and the exposure 
distributions in these cohorts, distance to 
the closest road was categorized as 0–49 m, 
50–99 m, 100–199 m, or ≥ 200 m (Adar and 
Kaufman 2007; Hart et al. 2009; Lipfert and 
Wyzga 2008; Zhu et al. 2002).
Covariates. To assess potential confound­
ing and effect modification, time­varying data 
from the biennial questionnaires were used 
for the following covariates: hyper  tension 
(yes or no regarding a diagnosis from a health 
professional), smoking status (never, former, 
or current), hypercholesterolemia (yes or no 
regarding a diagnosis from a health profes­
sional), alcohol consumption (0, 0.1–4.9, 
5.0–14.9, ≥ 15 g/day), and smoking pack­
years. Having a low­risk diet (yes, no) was 
assessed by semiquantitative food frequency 
questionnaires administered every 4 years and 
defined as a diet with a high ratio of polyun­
saturated to saturated fat that also was high in 
cereal fiber and low in trans fat and glycemic 
load (details described elsewhere) (Hu et al. 
2001b). Baseline body mass index (BMI; 
< 25.0, < 30.0, or ≥ 30.0 kg/m2) and physical 
activity [< 3, 3 to < 9, 9 to < 18, 18 to < 27, 
or ≥ 27 metabolic equivalent (MET) hr/week] 
were also included in models. We modeled 
baseline rather than time­varying values of 
BMI and physical activity to avoid adjust­
ing for factors that might be a consequence 
of the outcome, given that insulin resistance 
and DM could lead to reduced physical activ­
ity and thus increased BMI. For selection of 
covariates in final fully adjusted models, we 
evaluated changes (10% difference) in model 
estimates, but also opted to include some 
variables that might not have produced such 
a change in estimates but that are known risk 
factors for diabetes based on prior knowledge. 
Although some of the covariates may not have 
been identified previously as predictors of the 
exposure, it can be useful to adjust for these 
factors, as they reduce unexplained variation 
in the outcome and therefore increase power 
to detect the exposure.Puett et al.
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Statistical analysis. Time­varying Cox 
proportional hazards models were used to 
assess the relationship of DM with predicted 
PM2.5, PM10, and PM10–2.5 exposures in 
the 12 months before diagnosis and traffic­
related exposures, with each cohort analyzed 
individually. All survival models were based 
on a monthly time scale and were used to 
estimate hazard ratios (HRs) and 95% con­
fidence intervals (CIs). We assessed PM expo­
sure averaged over the 12 months before DM 
diagnosis because longer windows of exposure 
were highly correlated, and previous research 
has shown that time period to be the most 
relevant exposure for air pollution­related 
deaths (Schwartz et al. 2008). Person­months 
of follow­up time were calculated from base­
line (30 June 1989 for NHS and 30 January 
1989 for HPFS) until DM diagnosis, the end 
of follow­up (30 June 2002 for NHS and 
30 January 2002 for HPFS), censoring (mov­
ing outside the geographic region of interest 
or loss to follow­up), or death. Separate mod­
els assessed each particulate fraction alone, 
and a combined model examined PM2.5 and 
PM10–2.5 simultaneously. Cox models were 
stratified by age in months and adjusted for 
year (linear term) and state of residence. 
Because our PM analyses focused on expo­
sures averaged over 12 months, we also strati­
fied by season to adjust for seasonal changes in 
PM. Person­time spent living outside the geo­
graphic region of interest was excluded, rather 
than censoring the participant at the time of 
the move, as were nurses and health profes­
sionals with DM reported before baseline. 
Confounders were included in multivariable 
models individually, and HR modification 
was evaluated using p­values (< 0.05) from 
multiplicative interaction terms. In sensitiv­
ity analyses, we conducted analyses excluding 
women and men who reported myocardial 
infarctions (MIs) and cancer (except non­
melanoma skin cancer) prior to baseline. In 
addition, we performed sensitivity analyses 
restricted to symptomatic cases, defined as 
cases who had at least one of the following 
symptoms at diagnosis: ketoacidosis, unusual 
urinary frequency, coma, unusual hunger, 
unintended weight loss, unusual thirst, and 
visual changes for health professionals and 
nurses and, additionally, pruritis of the vulva/
vagina for nurses. To explore potential changes 
in the relationship of DM to air pollution 
exposures over time, we additionally estimated 
associations between DM and air pollution 
exposures during the first 2 years of follow­up 
and during the previous 2 years of follow­up, 
as well as for the average exposure across the 
study period. Random effects models were 
used to conduct a pooled meta­analysis to 
increase precision of the risk estimates and 
CIs, and heterogeneity was evaluated with the 
Q test (DerSimonian and Laird 1986). We 
performed all the statistical analyses using SAS 
(version 9.1; SAS Institute Inc., Cary, NC).
Results
There were 3,784 incident cases of DM 
among 74,412 eligible participants in the 
NHS (448 per 100,000 person­years) and 688 
cases among 15,048 eligible participants in the 
HPFS (402 per 100,000 person­years) (Table 
1). At baseline in 1989, the mean age was 
approximately 57 years for HPFS and 55 years 
for NHS participants. Most were never (NHS: 
43%, HPFS: 45%) or former smokers (NHS: 
36%, HPFS 46%). NHS participants were 
more likely than HPFS participants to have 
baseline BMI < 25 or > 30, although the 
preva  lence of hypertension at baseline was 
similar for both groups. Men in the HPFS 
were more physically active and consumed 
more alcohol than did women in the NHS. 
The means and SDs of baseline particulate 
exposures for the HPFS and NHS were similar 
for PM2.5 [18.3 (3.1) and 17.5 (2.7) µg/m3], 
PM10 [28.5 (5.5) and 26.9 (4.8) µg/m3], and 
PM10–2.5 [10.3 (3.3) and 9.4 (2.9) µg/m3]. 
Baseline addresses for HPFS participants were 
more likely than NHS addresses to be 0–49 m 
from the nearest road (22.3% vs. 9.8%) and 
less likely to be ≥ 200 m from the nearest road 
(63.7% vs. 77.5%).
Among the NHS, an interquartile range 
(IQR) increase of 4 µg/m3 in estimated 
PM10–2.5 averaged over the 12 months 
prior to diagnosis was associated with inci­
dent DM (HR = 1.07; 95% CI, 1.01–1.13) 
based on a single pollutant model stratified 
by age and adjusted for state of residence, 
year, and season (Table 2), but the HR was 
attenuated after additional adjustment for 
cigarette smoking, hypertension, BMI, alco­
hol intake, physical activity and diet (HR = 
1.04; 95% CI, 0.98–1.10). Associations with 
IQR increases in PM2.5 (IQR: 4 µg/m3) and 
PM10 (IQR: 6 µg/m3) were similar to those 
estimated for PM10–2.5 in fully adjusted mod­
els (PM2.5 HR = 1.02; 95% CI, 0.94–1.09; 
PM10 HR = 1.03; 95% CI, 0.98–1.09), and 
associations with PM2.5 and PM10–2.5 were 
similar when both were included in the same 
model. Estimates did not change appreciably 
when time­varying rather than baseline BMI 
was included or when family history of diabe­
tes, census tract median household value, or 
census tract median household income were 
added to models (data not shown). NHS par­
ticipants living < 50 m from the nearest road 
were more likely to be diagnosed with DM 
than those living ≥ 200 m away (fully adjusted 
HR = 1.14; 95% CI, 1.03–1.27) (Table 3). A 
nonsignificant (p > 0.05) association was also 
evident for women with residences located 
50–100 m from the nearest road.
Among the HPFS, estimated associa­
tions with DM were similar for IQR increases 
in PM2.5, (IQR: 4 µg/m3), PM10, (IQR: 7   
µg/m3), and PM10–2.5 (IQR: 4 µg/m3) aver­
aged over the previous 12 months (fully 
adjusted HR = 1.07; 95% CI, 0.92–1.24; 
1.06, 95% CI, 0.94–1.20; and 1.04, 95% CI, 
0.93–1.16, respectively) (Table 2). Estimated 
associations were similar when measures of 
neighborhood socioeconomic status (SES), 
time­varying rather than baseline BMI, and 
family history of diabetes were added to fully 
adjusted models (data not shown). Unlike the 
findings among women in the NHS with the 
fully adjusted multipollutant model, the risk 
of DM was greater for PM2.5 (HR = 1.06; 
95% CI, 0.89–1.26) than PM10–2.5 (HR = 
1.02; 95% CI, 0.89–1.16). In contrast with 
findings for the NHS, distance to the nearest 
road was not associated with incident DM 
among men in the HPFS (Table 3).
Pooled meta­analysis models adjusted for 
age, year, season, and state suggested a slight 
increase in diabetes incidence associated with 
an IQR increase in estimated PM10–2.5 and 
PM10 averaged over the 12 months prior to 
diagnosis (for both exposures: HR = 1.06; 
95% CI, 1.01–1.12), although associations 
were attenuated after full adjustment (for both 
Table 1. Descriptive characteristics of the NHS 
and HPFS participants at baseline, 1989.
Characteristic HPFS NHS
Participants (n) 15,048 74,412
Cases (n) 688 3,784
Age (years) 57.3 ± 9.7 55.1 ± 7.1
< 25.0 45.4 53.1
< 30.0 46.0 30.6
> 30.0 8.5 16.3
Smoking status
Never 44.9 43.0
Current 9.4 20.7
Former 45.7 36.3
Pack-years of smoking 25.0 ± 19.4 23.7 ± 19.4
Hypertension  26.1 26.8
High-risk diet 56.6 61.8
Alcohol consumption (g/day)
0 20.5 34.3
0.1–4.9 28.2 34.1
5.0–14.9 28.0 20.5
≥ 15.0 23.3 11.0
Physical activity (MET/hr/week)
< 3 15.2 25.3
3 to < 9 19.0 27.7
9 to < 18 19.0 20.0
18 to < 27 13.9 11.3
≥ 27 32.9 15.7
Predicted PM2.5 (µg/m3)a 18.3 ± 3.1 17.5 ± 2.7
IQR predicted PM2.5 (g/m3)a 4.0 4.3
Predicted PM10–2.5 (µg/m3)a 10.3 ± 3.3 9.4 ± 2.9
IQR predicted PM10–2.5 (µg/m3)a 4.2 3.7
Predicted PM10 (µg/m3)a 28.5 ± 5.5 26.9 ± 4.8
IQR predicted PM10 (µg/m3)a 7.2 6.3
Distance to road (m)
0–49  22.3 9.8
50–99  4.4 3.8
100–199  9.6 8.9
≥ 200  63.7 77.5
Data are presented as mean ± SD or percentages. 
aFor 12 months prior. PM exposures and diabetes
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exposures: HR = 1.04; 95% CI, 0.99–1.09) 
(Table 2). Associations with PM2.5 were some­
what weaker. Tests of heterogeneity between 
the NHS and HPFS were not significant for 
any of the pooled meta­analysis models, but 
a multiplicative interaction term between sex 
and PM2.5 was statistically significant in a fully 
adjusted model (p = 0.04) (data not shown). 
The pooled meta­analysis of DM incidence 
and proximity to roadways indicated a statisti­
cally significant association with an address 
0–49 m versus ≥ 200 m from the nearest road 
(HR = 1.11; 95% CI, 1.01–1.23) (Table 3).
Estimates from models adjusted for age, 
year, season, and state of residence, plus indi­
vidual covariates were generally similar to esti­
mates from fully adjusted models (data not 
shown). However, relative to basic models, 
adjusting for baseline BMI slightly attenu­
ated associations with all size fractions of 
PM in the NHS (e.g., HR for PM2.5 in basic 
model adjusting for BMI = 1.02; 95% CI, 
0.94–1.09) but slightly increased the HR for 
PM2.5 in the HPFS (HR = 1.08; 95% CI, 
0.93–1.25). No evidence of effect modifica­
tion was found for any of the covariates exam­
ined (data not shown).
Estimates from models that excluded par­
ticipants with a baseline history of MI (leaving 
3,672 NHS and 604 HPFS cases) or prior 
cancer (except nonmelanoma skin cancer) 
(leaving 3,311NHS and 522 HPFS cases) 
were similar to the reported estimates (data 
not shown). Compared with estimates from 
our original HPFS study population, analyses 
restricted to symptomatic DM cases (366) 
suggested a slightly lower, although still null, 
risk of incident DM with an IQR increase in 
PM exposures (fully adjusted PM2.5 HR = 
0.96; 95% CI, 0.78–1.17; PM10 HR = 0.97; 
95% CI, 0.82–1.15; PM10–2.5 HR = 0.98; 
95% CI, 0.85–1.14). Results for symptomatic 
NHS participants (3,379) were comparable 
with those for all cases (data not shown).
In sensitivity analyses restricted to the 
first 2 years of follow­up, relative risks (RRs) 
for NHS women with IQR increases in all 
three particle fraction exposures were lower 
than for the full time period of follow­up, but 
higher when analyses were restricted to the 
final 2 years of follow­up (Table 4). Among 
men in the HPFS, associations were stronger 
with PM2.5 during the first 2 years and with 
all size fractions in the last 2 years than for 
the full period of follow­up, whereas the asso­
ciation with PM10–2.5 during the first 2 years 
was weaker.
When associations were estimated with 
IQR increases in PM exposures averaged over 
the entire follow­up period (instead of during 
the 12 months prior to diagnosis), there was 
no evidence of associations between incident 
DM and any PM size fraction among NHS 
women, and associations with PM2.5 and 
PM10 were attenuated for HPFS men (data 
not shown). In pooled meta­analyses, HRs 
for incident DM associated with average PM 
exposures over the entire follow­up period 
were 0.99 (95% CI, 0.89–1.10) for PM2.5; 
0.98 (95% CI, 0.91–1.06) for PM10; and 
1.02 (95% CI, 0.93–1.12) for PM10–2.5.
Discussion
Overall findings for these two cohorts of 
nurses and health professionals living in the 
Northeast and Midwest indicate weak non­
statistically significant increased risks of inci­
dent DM associated with IQR increases in 
predicted PM2.5, PM10, and PM10–2.5 aver­
aged over the 12 months prior to diagnosis. 
RR estimates were very similar for each size 
PM fraction, with overlapping CIs. Among 
NHS participants, the strongest fully adjusted 
association was with PM10–2.5, whereas 
Table 2. HRs (95% CIs) for diabetes associated with an IQR increasea in average-predicted PM exposure in the 12 months before diagnosis.
NHS (3,784 cases, 844,490 person-years) HPFS (688 cases, 167,310 person-years) Pooled meta-analysis
Age, season, year, 
state adjusted Fully adjustedb
Age, season, year, 
state adjusted Fully adjustedb
Age, season, year, 
state adjusted Fully adjustedb
Single pollutant models
PM2.5 1.04 (0.97–1.12) 1.02 (0.94–1.09) 1.05 (0.91–1.22) 1.07 (0.92–1.24) 1.05 (0.98–1.12) 1.03 (0.96–1.10)
PM10 1.06 (1.00–1.12) 1.03 (0.98–1.09) 1.06 (0.93–1.20) 1.06 (0.94–1.20) 1.06 (1.01–1.12)* 1.04 (0.99–1.09)
PM10–2.5 1.07 (1.01–1.13)* 1.04 (0.98–1.10) 1.05 (0.94–1.17) 1.04 (0.93–1.16) 1.06 (1.01–1.12)* 1.04 (0.99–1.09)
Multipollutant models
PM2.5 1.01 (0.93–1.09) 0.99 (0.92–1.08) 1.04 (0.91–1.18) 1.06 (0.89–1.26) 1.01 (0.94–1.09) 1.00 (0.93–1.08)
PM10–2.5 1.06 (1.00–1.13) 1.04 (0.98–1.11) 1.02 (0.86–1.22) 1.02 (0.89–1.16) 1.06 (1.00–1.12)* 1.04 (0.98–1.10)
aPM2.5 IQR = 4 µg/m3; PM10, IQR = 7 µg/m3; and PM10–2.5 IQR = 4 µg/m3. bAdjusted for age, season, calendar year, state of residence, time-varying cigarette smoking (status and pack-
years), time-varying hypertension, baseline BMI, time-varying alcohol intake, baseline physical activity, and time-varying diet. *p < 0.05.
Table 3. HRs and 95% CIs for diabetes associated with proximity to nearest road.
NHS (4,037 cases, 869,072 person-years) HPFS (715 cases, 172,283 person-years) Pooled meta-analysis
Age, season, year, 
state adjusted Fully adjusteda
Age, season, year, 
state adjusted Fully adjusteda
Age, season, year, 
state adjusted Fully adjusteda
Distance to road (m)
0–49  1.20 (1.08–1.33)* 1.14 (1.03–1.27)* 0.99 (0.82–1.19) 1.02 (0.85–1.23) 1.11 (0.92–1.33) 1.11 (1.01–1.23)
50–99  1.20 (1.03–1.40)* 1.16 (0.99–1.35) 0.76 (0.51–1.14) 0.74 (0.49–1.11) 0.99 (0.64–1.54)** 0.96 (0.63–1.48)**
100–199  1.02 (0.92–1.14) 0.97 (0.88–1.08) 0.86 (0.66–1.13) 0.88 (0.67–1.16) 0.99 (0.86–1.13) 0.96 (0.87–1.06)
≥ 200  1.00 (referent) 1.00 1.00  1.00 1.00 1.00
aAdjusted for age, season, calendar year, state of residence, time-varying cigarette smoking (status and pack-years), time-varying hypertension, baseline BMI, time-varying alcohol 
intake, baseline physical activity, and time-varying diet. *p < 0.05. **p < 0.05 for heterogeneity between the NHS and HPFS.
Table 4. HRs for diabetes associated with an IQR increasea before 12 months PM exposure for first and 
final 2 years of follow-up.
NHS HPFS
Fully adjusted modelb HR (95% CI) Fully adjusted modelb HR (95% CI)
First 2 yearsc 438 cases, 151,967 person-years 94 cases, 1,996 person-years
PM2.5 0.98 (0.80–1.18) 1.13 (0.79–1.62)
PM10 1.01 (0.87–1.17) 1.04 (0.76– 1.42)
PM10–2.5  1.03 (0.89–1.19) 0.94 (0.70– 1.27)
Last 2 yearsd 593 cases, 135,213 person-years 129 cases, 23,670 person-years
PM2.5 1.21 (1.00–1.46) 1.52 (0.93–2.47)
PM10 1.13 (0.98–1.29) 1.27 (0.91–1.77)
PM10–2.5 1.09 (0.94–1.25) 1.13 (0.88–1.45)
aPM2.5 IQR = 4 µg/m3; PM10 IQR = 7 µg/m3; and PM10–2.5 IQR = 4 µg/m3. bAdjusted for age, season, calendar year, state 
of residence, time-varying cigarette smoking (status and pack-years), time-varying hypertension, baseline BMI, time-
varying alcohol intake, baseline physical activity, and time-varying diet. c1989–1991. d2000–2002.Puett et al.
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the weakest was with PM2.5. This pattern 
was reversed in the HPFS, with the weak­
est association observed for PM10–2.5 and the 
strongest with PM2.5. Although the addition 
of a multiplicative interaction term in the 
fully adjusted model for PM2.5 was signifi­
cant, showing a greater risk among men, the 
pooled meta­analysis did not show a differ­
ence, possibly because of differences in how 
each analytic method deals with adjustment 
by covariates. Multipollutant models, analyses 
restricted to symptomatic DM, and analyses 
restricted to the first 2 years of follow­up were 
similar. In general, results were weaker for PM 
exposures averaged over the entire follow­up 
period. RRs were stronger for DM during the 
final 2 years of follow­up, although CIs were 
wider because of the reduction in sample size. 
Finally, fully adjusted estimates showed a sta­
tistically significant association with DM for 
NHS women living < 50 m versus > 200 m 
from the nearest road. However, distance to 
the nearest road was not associated with DM 
among the HPFS .
The body of research on associations 
between diabetes and air pollution exposures 
is currently very limited. Although direct com­
parisons with our study results are not pos­
sible because of differences in the pollutants, 
diabetes type, and age groups studied, other 
studies have also shown weak evidence of an 
association between diabetes and PM expo­
sures and stronger evidence for traffic­related 
pollutants (represented by distance from the 
nearest road in our study). Brook et al. (2008) 
reported a 4% increase in the adjusted odds 
(95% CI, 1.00–1.08, p = 0.03) of DM diag­
nosis with each ppb increase in NO2 expo­
sure among 4,182 women in Hamilton and 
Toronto, Canada, but no association among 
the 3,452 men in the study [odds ratio (OR) 
= 0.99; 95% CI, 0.95–1.03]. In a study of 
402 children in Southern California, type 1 
diabetes was not significantly associated with a 
10­µg/m3 increase in average PM10 from birth 
to diagnosis (OR = 1.08; 95% CI, 0.87–1.34) 
or a 10­ppb increase in NO2 (OR = 1.03; 95% 
CI, 0.71–1.50) but was significantly associated 
with a 10­ppb increase in O3 (OR = 2.92; 95% 
CI, 1.86–4.58) and SO4 (OR = 1.65; 95% CI, 
1.20–2.28) (Hathout et al. 2006). In a smaller 
study of 100 children, designed as two case–
control studies—one among younger children 
and another among older children, Hathout 
et al. (2002) reported a significant association 
between type 1 diabetes diagnosis and average 
prediagnosis PM10 among children under age 
six years, but not among older children. In 
both age groups, type 1 diabetes was associated 
with average birth to diagnosis exposure to O3, 
but not to NO2 or SO4.
Evidence of associations between air pol­
lution exposures and diabetes mortality is 
also somewhat inconsistent. In a time series 
study of 434 diabetes deaths in Shanghai, 
Kan (2004) found a weak association with a 
10­µg/m3 increase in 1­day lagged PM10 (RR 
= 1.01; 95% CI, 1.00–1.01) and a 10­µg/m3 
increase in 1­day lagged NO2 (RR = 1.01; 
95% CI, 1.00–1.03). A study of mortality 
among Montreal, Canada, residents registered 
with the universal Quebec Health Insurance 
Plan included 3,677 deaths from diabetes 
(Goldberg et al. 2006). Some associations 
were reported between daily diabetes mortal­
ity and the 3­day mean during the warm or 
cold season for certain air pollutants generated 
from combustion sources (e.g., sulfate, PM2.5, 
NO2) in individuals who also had cardio­
vascular disease, cancer, or respiratory disease. 
No associations were reported for individuals 
without these conditions. In a case­crossover 
study of 100,000 deaths from 1995 to 2002, 
an interquartile increase (0.203 g/m black   
carbon) in traffic particle exposure the day 
before death was associated with a 5.7% (95% 
CI, –1.7 to 13.7) increase in deaths due to 
DM (Maynard et al. 2007).
Biological mechanisms proposed to 
explain associations between air pollution and 
cardiovascular disease, specifically, inflamma­
tion, oxidative stress, and endothelial dysfunc­
tion, are also plausible mechanisms linking 
air pollution with the development or exac­
erbation of diabetic conditions. However, the 
majority of literature to date suggests that 
DM is an effect modifier of the relationship 
between air pollution exposures and cardio­
vascular outcomes, as opposed to being 
a direct consequence of air pollution expo­
sures. Zanobetti and Schwartz (2001, 2002) 
reported that the percent increase in cardio­
vascular hospitalizations associated with a 
10­µg/m3 increase in mean PM10 exposure 
on the day of and day before admission was 
almost doubled among persons with diabetes 
compared with the percent increase among 
those without diabetes. Comparable findings 
of stronger associations between air pollution 
exposures and cardiovascular­associated hos­
pitalizations and emergency department visits 
among persons with diabetes compared with 
those without diabetes have been reported 
by other researchers (Peel et al. 2007; Pereira 
Filho et al. 2008). Research has suggested 
that inflammatory mechanisms are involved 
in strengthening the impact of air pollution 
among persons with diabetes. Increased levels 
of inflammatory biomarkers, C­reactive pro­
tein and IL­6 were more strongly associated 
with PM2.5 exposures among persons with 
diabetes compared with persons without the 
disease (Dubowsky et al. 2006). Decreases in 
flow­mediated vascular reactivity and nitro­
glycerin­mediated reactivity were associated 
with increases in 6­day moving average black 
carbon and PM2.5 exposures, respectively, 
among a population of diabetics, whereas 
similar decreases were not evident among 
those at risk for diabetes (O’Neill et al. 2005).
Although this study helps address the gap 
of information regarding direct links between 
air pollution and diabetes, limitations and 
strengths must be considered. We included 
only confirmed and probable DM cases based 
on National Diabetes Group and American 
Diabetes Association criteria (National 
Diabetes Data Group 1979); however some 
persons with diabetes may have been mis­
classified because we relied initially on self­
reported diagnosis rather than on glucose 
testing for all cohort participants. Although 
we had the advantage of using data from large 
prospective cohorts, our power to detect an 
effect among the HPFS men was somewhat 
limited by the sample size, particularly in 
sensitivity analyses restricted to symptom­
atic DM cases. In addition, the meta­analyses 
and combined analyses with sex­interaction 
terms were dominated by the NHS because 
of a smaller number of HPFS participants. In 
addition, although results were consistent for 
the two time periods of average PM exposure, 
we evaluated (12 months before diagnosis and 
exposures averaged over the entire follow­up 
period), additional time windows of expo­
sure should be explored, including more acute 
exposures and exposures during childhood.
As in our previously published studies of 
the NHS (Puett et al. 2008, 2009), the GIS­
based temporal spatial smoothing of our PM 
predictive models reduced variability relative 
to measured concentrations. This Berkson 
measurement error should not cause sub­
stantial bias toward the null (Gryparis et al. 
2009). However, it is possible that differences 
between study populations with respect to 
traffic­related exposures (distance to the near­
est road) and PM2.5 associations, may be due 
in part to differences in the type of address 
available for each study—residential only in 
the NHS versus occupational or residential 
in the HPFS—rather than differences in sus­
ceptibility between men and women. Thus, 
error in the predicted exposure estimates for 
the HPFS would differ from the NHS. For 
the HPFS, however, both address types are 
likely to represent PM exposures during a 
large part of a 24­hr period, albeit different 
parts. Finally, unlike many previous stud­
ies, the availability of geocoded biennially 
updated addresses enabled us to adjust for a 
number of biennially updated individual­level 
covariates and to assign predicted particu­
late exposure levels to each address for each 
participant throughout the follow­up period. 
Therefore, exposure estimates should be more 
accurate over time than estimates based on 
baseline addresses only. In addition, missing 
exposure data were minimized because of the 
use of a recently developed and highly specific 
GIS­based spatial smoothing model.PM exposures and diabetes
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Because of the mixed nature of the HPFS 
addresses, we did not believe it was appropri­
ate to assess area­level SES as a confounder in 
this study. However, estimates from models 
adjusted for neighborhood­level SES, such as 
median house value and average household 
income at the census­tract level (U.S. Census 
2000) were similar to those presented for both 
the HPFS and NHS. An additional potential 
limitation of our analysis was that our two 
populations of health professionals represent 
a narrow range of SES, possibly limiting the 
generalizability of our results.
Conclusion
In summary, we did not find strong evidence 
for an association between exposure to PM2.5, 
PM10, or PM10–2.5 in the 12 months before 
diagnosis and type 2 DM incidence among 
female nurses and male health professionals 
living in the northeastern and midwestern 
United States. However, our findings did sug­
gest an association between residential prox­
imity to roadways and incident DM among 
female nurses. Although questions remain 
regarding which pollutants play the most 
prominent role in incident DM and which 
subpopulations are most susceptible, our 
study results add to other findings reported 
in the current literature suggesting that DM 
may be an outcome of air pollution exposures 
in addition to being an effect modifier for air 
pollution–associated cardiovascular disease.
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